Your browser is no longer supported. Please, upgrade your browser.
Settings
PKI PerkinElmer, Inc. daily Stock Chart
PKI [NYSE]
PerkinElmer, Inc.
IndexS&P 500 P/E44.58 EPS (ttm)2.65 Insider Own0.30% Shs Outstand111.33M Perf Week-1.28%
Market Cap13.33B Forward P/E20.50 EPS next Y5.75 Insider Trans-11.27% Shs Float110.90M Perf Month1.50%
Income294.10M PEG2.63 EPS next Q1.43 Inst Own95.30% Short Float2.31% Perf Quarter22.96%
Sales2.98B P/S4.48 EPS this Y-2.70% Inst Trans-1.01% Short Ratio2.84 Perf Half Y49.30%
Book/sh26.65 P/B4.43 EPS next Y6.69% ROA4.50% Target Price123.14 Perf Year39.61%
Cash/sh1.93 P/C61.02 EPS next 5Y16.95% ROE10.50% 52W Range62.91 - 123.21 Perf YTD21.48%
Dividend0.28 P/FCF32.32 EPS past 5Y7.70% ROI6.50% 52W High-4.26% Beta1.32
Dividend %0.24% Quick Ratio0.90 Sales past 5Y5.20% Gross Margin50.30% 52W Low87.51% ATR2.94
Employees13000 Current Ratio1.30 Sales Q/Q12.30% Oper. Margin13.60% RSI (14)52.16 Volatility2.45% 2.57%
OptionableYes Debt/Eq0.66 EPS Q/Q97.80% Profit Margin9.90% Rel Volume0.72 Prev Close117.58
ShortableYes LT Debt/Eq0.55 EarningsJul 28 AMC Payout10.50% Avg Volume900.63K Price117.96
Recom2.30 SMA200.49% SMA501.10% SMA20020.72% Volume646,827 Change0.32%
Sep-11-20Upgrade Needham Hold → Buy $139
Jul-29-20Upgrade CFRA Hold → Buy
Jan-08-20Initiated Wells Fargo Equal Weight $105
Jan-07-20Initiated Citigroup Neutral $100
Jan-02-20Upgrade Evercore ISI In-line → Outperform
Nov-15-19Initiated Stifel Buy
Oct-31-19Downgrade Piper Jaffray Overweight → Neutral $104 → $89
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $105
May-30-19Initiated Wolfe Research Peer Perform
Apr-09-19Upgrade Goldman Neutral → Buy $115
Jan-03-19Initiated Needham Hold
Nov-02-18Downgrade Janney Buy → Neutral
Oct-09-18Initiated UBS Neutral
Sep-10-18Reiterated Deutsche Bank Hold $88 → $93
Dec-19-17Upgrade BofA/Merrill Underperform → Neutral
Sep-26-17Resumed Goldman Neutral $67
Jul-13-17Initiated Wells Fargo Market Perform
Feb-03-17Downgrade BofA/Merrill Neutral → Underperform
Jan-18-17Initiated Deutsche Bank Hold $55
Aug-05-16Downgrade Mizuho Buy → Neutral $56
Sep-19-20 12:46PM  
Sep-17-20 11:30AM  
Sep-16-20 05:21PM  
Sep-12-20 11:52AM  
Sep-11-20 04:34PM  
01:03PM  
09:38AM  
Sep-09-20 08:32AM  
Sep-04-20 08:00AM  
Sep-01-20 11:30AM  
07:20AM  
Aug-31-20 11:46AM  
Aug-27-20 11:31AM  
08:33AM  
Aug-26-20 04:55PM  
Aug-19-20 04:15PM  
08:35AM  
Aug-18-20 09:24AM  
08:04AM  
Aug-17-20 10:39AM  
09:00AM  
Aug-14-20 07:55AM  
Aug-13-20 08:06AM  
Aug-12-20 01:10PM  
01:09PM  
11:30AM  
08:41AM  
07:10AM  
Aug-11-20 08:10AM  
Aug-10-20 08:17AM  
05:43AM  
Aug-06-20 09:27AM  
09:26AM  
09:26AM  
09:22AM  
Aug-05-20 09:47AM  
09:08AM  
Aug-04-20 05:53PM  
05:39PM  
08:14AM  
Aug-03-20 12:00PM  
Jul-30-20 12:20PM  
Jul-29-20 12:35PM  
09:42AM  
Jul-28-20 10:31PM  
06:05PM  
04:15PM  
09:20AM  
Jul-27-20 08:34PM  
08:34AM  
07:00AM  
Jul-24-20 07:43PM  
Jul-23-20 04:15PM  
09:29AM  
Jul-22-20 07:28AM  
Jul-21-20 12:10PM  
08:00AM  
Jul-20-20 03:05AM  
Jul-17-20 12:00PM  
Jul-13-20 11:08AM  
08:38AM  
08:00AM  
Jun-20-20 03:00AM  
Jun-19-20 09:13AM  
Jun-18-20 03:14PM  
10:49AM  
Jun-12-20 12:34PM  
Jun-04-20 11:31AM  
08:48AM  
May-20-20 04:15PM  
May-18-20 09:44AM  
09:28AM  
07:17AM  
May-15-20 03:04PM  
May-06-20 10:23AM  
06:35AM  
01:01AM  
May-05-20 05:35PM  
04:15PM  
09:15AM  
May-03-20 03:45PM  
May-01-20 04:15PM  
Apr-30-20 04:15PM  
Apr-28-20 12:33PM  
Apr-21-20 06:08PM  
Apr-20-20 03:39PM  
Apr-14-20 08:30AM  
Apr-13-20 04:15PM  
11:01AM  
Mar-30-20 04:41AM  
Mar-27-20 09:44AM  
Mar-26-20 10:25AM  
Mar-25-20 07:01AM  
Mar-24-20 05:32PM  
05:13PM  
Mar-18-20 11:32AM  
06:26AM  
Mar-17-20 02:08PM  
08:49AM  
Mar-09-20 11:57AM  
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophym, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldberg Joel SPlease See RemarksJul 31Option Exercise43.0123,3871,005,87595,179Aug 03 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Sale117.8423,3872,755,82571,792Aug 03 04:05 PM
Okun AndrewPlease See RemarksJul 29Option Exercise52.654,699247,40217,009Jul 30 06:42 PM
Okun AndrewPlease See RemarksJul 29Sale120.006,699803,88010,310Jul 30 06:42 PM
Tereau Daniel RPlease See RemarksJun 15Option Exercise43.743,242141,78912,879Jun 16 04:06 PM
Tereau Daniel RPlease See RemarksJun 15Sale95.225,452519,1397,427Jun 16 04:06 PM
Barrett PeterDirectorMay 28Option Exercise42.094,750199,90429,552May 29 04:06 PM
Barrett PeterDirectorMay 28Sale100.117,552756,03822,001May 29 04:06 PM
MICHAS ALEXIS PDirectorFeb 10Option Exercise30.51752,28861,691Feb 11 04:16 PM
MICHAS ALEXIS PDirectorFeb 05Option Exercise30.515,526168,59863,386Feb 06 04:05 PM
MICHAS ALEXIS PDirectorFeb 05Sale96.231,777171,00261,609Feb 06 04:05 PM
Okun AndrewPlease See RemarksDec 04Option Exercise52.659,398494,80518,280Dec 05 04:05 PM
Okun AndrewPlease See RemarksDec 04Sale90.8711,9841,088,9866,296Dec 05 04:05 PM
Witz PascaleDirectorNov 21Sale90.671,04394,5692,446Nov 22 04:05 PM